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ABSTRACT
We have recently described a Dilute-‘N’-Go protocol
that greatly simplifies preparation and sequencing
of both strands of an amplicon generated using
linear-after-the-exponential (LATE)-PCR, an
advanced form of asymmetric PCR . The same
protocol can also be used to sequence all limiting
primer strands in a multiplex LATE-PCR, by adding
back each of the depleted limiting primers to a
separate aliquot of the multiplex reaction. But,
Dilute-‘N’-Go sequencing cannot be used directly
to sequence each of the excess primer strands in
the same multiplex reaction, because all of the
excess primers are still present at high concentra-
tion. This report demonstrates for the first time that
it is possible to sequence each of the excess primer
strands using a modified Dilute-‘N’-Go protocol in
which blockers are added to prevent all but one of
the excess primers serving as the sequencing
primer in separate aliquots. The optimal melting
temperatures, positions and concentrations of
blockers relative to their corresponding excess
primers are defined in detail. We are using these
technologies to measure DNA sequence changes
in mitochondrial genomes that accompany aging
and exposure to certain drugs.
INTRODUCTION
A host of novel sequencing methods are being developed
for rapidly sequencing whole genomes by in silico splicing
of short overlapping DNA sequences (1–5). Nevertheless,
dideoxy sequencing remains the method of choice for
sequencing PCR amplicons up to 1000 bases long, even
though preparation and clean-up of such amplicons prior
to sequencing is still a time consuming and expensive bot-
tleneck to high-throughput dideoxy sequencing. The con-
ventional approach to sample preparation is to remove
unused primers, nucleotides and enzyme present at the
end of ampliﬁcation by ﬁltration, chromatography or gel
electrophoresis and then add a standard sequencing
cocktail (6). Enzymatic methods have also been
employed for the removal of interfering components
(7–9). None of these procedures, however, solves the
problem of sequencing all of the strands generated in a
single tube multiplex reaction.
Linear-after-the-exponential (LATE)-PCR is an
advanced form of asymmetric PCR that uses a limiting
primer (LP) and an excess primer (XP) to exponentially
amplify double-stranded DNA eﬃciently and then pre-
dictably switches to linear ampliﬁcation of single-stranded
DNA (10,11). Limited amount of LP strand, the DNA
strand extended from the LP, has been generated. While
the LP is no longer present at the end of the reaction and a
high concentration of the XP strand has accumulated,
unused XP is still abundant. The LP strand can readily
be sequenced by simply diluting an aliquot of the reaction
into distilled water containing a few picomoles of the LP
used for ampliﬁcation of the double-stranded amplicon.
The solution is so diluted that the LP strand as the
template for sequencing the XP strand has been diluted
out. Therefore, no XP strand sequence can be obtained.
The added LP primer serves as the sequencing primer
while the XP strand serves as template when an aliquot
of the mixture is added to a cocktail for commercial
dideoxy sequencing (12). We have also adapted this
approach for pyrosequencing (13). In the case of
dideoxy sequencing, a second aliquot of a monoplex
reaction can be diluted and added to a commercial
sequencing cocktail without addition of the LP. In this
case, the XP still present in the reaction serves as the
sequencing primer and the LP strand serves as template.
We have recently shown that sequencing carried out in this
way is accurate, even when PCR ampliﬁcation is initiated
with as little as a single DNA molecule (14).
Multiplex LATE-PCR assays generate separate
single-stranded XP strand for each of the amplicons.
Each of these strands can be used as a sequencing
template by spiking separate aliquots of the reaction
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depleted. The ﬁdelity of the resulting set of sequences
can be conﬁrmed by comparison to each of the corre-
sponding sequences generated in its own monoplex
reaction (12). But, the ﬁdelity of the set of sequences
derived from the multiplex reaction cannot be conﬁrmed
by sequencing each of the complementary strands in the
same multiplex reaction using the standard Dilute-‘N’-Go
protocol. This is because all of the XPs are still present in
the reaction product and can generate a set of overlapping
sequences.
In this paper, we introduce the use of blockers in con-
junction with Dilute-‘N’-Go sequencing in multiplex
LATE-PCR assays. A blocker (BLK) is designed to
compete with hybridization of the 30-end of the XP to its
binding site on its target, thereby preventing primer elon-
gation during each thermal cycle of the sequencing
reaction. All but one of the XPs is blocked in each
aliquot of the diluted multiplex reaction product. Only
the XP that is not blocked in that aliquot functions as a
sequencing primer. The conditions for using this strategy
were optimized using a duplex LATE-PCR assay and then
were applied to a triplex assay comprised of three
amplicons for the human mitochondrial genome. This
assay is being built and tested in order to be able to
monitor mutagenesis at the single genome level caused
by either aging or azidothymidine (AZT), a drug used to
inhibit the HIV reverse transcriptase.
MATERIALS AND METHODS
Synthesis and puriﬁcation of oligonucleotides
Primers:
G269_LP: 50-CGAGGTCATTGAATACGCACGGCTCC-30,
G269_XP: 50-GCGCTGTGCCCTTACATAGTCT-30,
HV1_LP: 50-CACCAGTCTTGTAAACCGGAGATGAAAACC-30,
HV1_XP: 50-CGAGGAGAGTAGCACTCTT-30,
TSD_LP: 50-CCGCCCTTCTCTCTGCCCCCTGGT-30,
TSD_XP: 50-CCGGGTCTCTAAGGGAGAACTCCT-30,
Globin_LP: 50-GGCCATCACTAAAGGCACCGAGCACT-30,
Globin_XP: 50-TGGGTTTCTGATACGCACTGACTCTCTC-30,
HV2_LP: 50-AGCGGTGTGTGTGTGCTGGGTAGGAT-30,
HV2_LPs2: 50-GTTATGATGTCTGTGTGGAAAGTG-30,
HV2_XP: 50-ACAGGTCTATCACCCTATTAACCACTCA-30,
HV2_XPs2: 50-TTCTGGCCACAGCACTTAAAC-30,
Cytb_LP: 50-CAGGTTAGAATGAGGAGGTCTGCGGCT-30,
Cytb_XP: 50-ACCTCCTATTCTTGCACGA-30,
were synthesized and salt-free puriﬁed by Euroﬁns MWG
Operon (AL, USA).
Blockers:
G269_BL: 50-GCGCTGTGCCCTTACATAGTCTAACAGT
AC-30-BHQ1,
HV1_BL: 50-CGAGGAGAGTAGTACTCTTGTGCGGG
A-30-BHQ1,
HV1_BL1: 50-GAGGAGAGTAGTACTCTTGTGCGGG
A-30-BHQ1,
HV1_BL3: 50-CTTGTGCGGGATATTGATTTCACGG-30-BHQ1,
HV1_BL4: 50-TGTGCGGGATATTGATTTCACGGAG
G-30-BHQ1,
HV1_BL6: 50-CGAGGAGATTAGTACTCTTGTGCGGG
A-30-BHQ1,
HV1_BL7: 50-CGAGGAGATTAGTACTCTTATGCGGG
A-30-BHQ1,
HV1_BL8: 50-CGAGGAGATAAGTACTCTTATGCGGG
A-30-BHQ1,
HV1_EB: 50-CGAGGAGAGTAGCACTCTT-30-BHQ1,
TSD_BL: 50-CCGGGTCTCTAAGGGAGAACTCCTGCTCTC
A-30-BHQ1,
TSD_BLm: 50-CCGGGTATCTAAGGGAGAACTCCTGCTCTC
A-30-BHQ1,
Globin_BL:
50-TGGGTTTCTGATAGGCACTGACTCTCTCTGCCTA
TTGG-30-BHQ1,
HV2_BL: 50-ACAGGTCTATCACCCTATTAACCACTCAC
G-30-BHQ1,
Ctyb_BL: 50-ACCTCCTATTCTTGCACGAAACGGGATC
A-30-BHQ1,
were synthesized and double HPLC puriﬁed by Biosearch
Technologies (CA, USA).
LATE-PCR conditions
All PCR reactions had the following reagents: 1  PCR
buﬀer, 0.2mM dNTPs, 3mM MgCl2, 2 units of Platinum
Taq DNA polymerase (InVitrogen, CA, USA), 50nM of
each LP, 1mM of each XP and 0.24  SYBR Green I in a
25ml volume. For G269 & HV1 duplex and TSD & Globin
duplex, 300nM PrimeSafe
TM I (12) and 1000 genomes of
puriﬁed human genomic DNA were included. For
mitochondrial DNA HV1, HV2 and Cyt b triplex,
300nM PrimeSafe
TM II and 100K copies of
mitochondrial DNA from puriﬁed human DNA were
included. LATE-PCR ampliﬁcation and ﬂuorescence
detection were carried out in a Stratagene Mx 3005 PCR
thermocycler.
Thermal cycling proﬁle for G269 & HV1 duplex and
TSD & Globin duplex included an initial denaturation
step of 5min at 95 C, followed by 55 cycles of 95 C for
10s, 64 C for 20s and 72 C for 1min, then a melting from
55 to 95 C with a 1 C increase. The thermocycler temper-
ature program for the mitochondrial DNA HV1, HV2 and
Cyt b triplex consisted of denaturation at 95 C for 5min,
followed by 60 cycles of 95 C for 30s, 62 C for 20s and
72 C for 45s, then a melting from 35 to 95 C with a 1 C
increase. The completed LATE-PCR samples were kept at
 20 C until sequenced. The ﬂuorescence reading in all
assays was taken at 72 C.
Sample preparation for dideoxynucleotide sequencing
No puriﬁcation of the LATE-PCR product was per-
formed. Dideoxy sequencing was performed by
GENEWIZ, Inc (South Plainﬁeld, NJ) using Applied
Biosystems BigDye version 3.1. The reactions were then
run on Applied Biosystems’s 3730x1 DNA analyzer.
Standard cycle sequencing includes an initial denaturation
at 96 C for 1min, followed by 25 cycles of 96 C for 10s,
50 C for 5s and 60 C for 1min. The premixed samples
were diluted 2  in GENEWIZ before the reaction. For
the sequencing of the limiting primer strand, 1ml DNA
from a 10  diluted LATE-PCR that has completed
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containing 1mM of the same LP used in the LATE-PCR
or another inner sequencing primer. For the sequencing of
the XP strand, 1ml DNA from LATE-PCR is diluted to
12ml with 1mM of each BLK, unless speciﬁed otherwise in
the text. In order to obtain the whole sequence or the
second half of the HV2 amplicon, the HV2 XP was
blocked along with the other XPs in the triplex reaction
and a separate downstream sequencing primer was added
at 1mM.
Tm calculation
Tm is deﬁned as the temperature at which, for a given
concentration of primer or BLK at the start of the
reaction, half of the target is bound to that primer or
BLK to form a heterodimer. The Tm of each primer or
BLK can be obtained from the corresponding binding
curve to its target simulated by VisualOMP V7 (DNA
software, CA) as shown in Figure 1b. The simulation is
performed under sequencing conditions with all target
concentration set as 2.5nM, all XP concentrations set at
25nM and all BLK concentrations set at 500nM unless
described otherwise in the text.
RESULTS
Blockers: rationale and proof of concept
All of the multiplex LATE-PCR assays described here
contained 50nM of each LP and 1mM of each XP at
the start of the reaction. At the end of the exponential
phase of ampliﬁcation all LPs are depleted, but each XP
is still present at  500nM after 20–30 additional cycles of
linear ampliﬁcation. If an aliquot of a multiplex reaction
is simply diluted into a commercial sequencing cocktail,
each XP will hybridize to its speciﬁc target and will
generate a ladder of oligonucleotides. All such ladders
will overlap making it impossible to discern individual
sequence. Therefore, to use the Dilute-‘N’-Go protocol
for sequencing each of the XP strands generated in a
multiplex LATE-PCR assay it is necessary to block exten-
sion of all-but-one of the XPs present in the reaction. This
is accomplished by adding all possible sets of all-but-one
BLKs to parallel aliquots of the reaction products. In
order to be eﬀective all BLKs have to: (i) speciﬁcally
hybridize to their intended LP strand; (ii) overlap the
30 end of the corresponding XP and (iii) bind to their
target sequences more rapidly than the corresponding XP.
Figure 1a shows the simplest way to design BLKs to
meet these criteria. The BLKs for both G269 and HV1 are
both oligonucleotides 5–10 bases longer on their 30-ends
than the XPs with which they compete. The 30-end of both
BLKs is capped with a BHQ-1 (Black Hole Quencher-1)
when ordered from Biosearch Technologies although a
carbon linker is equally eﬀective (data not shown). Each
BLK is perfectly matched to its target and therefore has a
Tm at least 5 C higher than that of its corresponding XP.
In silico melting proﬁles show that the two BLKs saturate
the targets before the XPs as the temperature drops
(Figure 1b).
The Dilute-‘N’-Go sequencing results, Figure 1c, show
that the addition of the HV1 BLK resulted in a clean
sequence for G269 XP strand, while addition of the
G269 BLK to a second aliquot resulted in a clean
sequence for HV1 XP strand. Omission of both BLKs,
but addition of the LP for G269 to a third aliquot
generated a clean sequence for the G269 LP strand,
while addition of the LP for HV1 to a forth aliquot
generated a sequence for the HV1 LP stand. The
sequences of the two HV1 and the two G269 strands are
complementary when aligned right-to-left/left-to-right.
It is worth emphasizing that preparation of the four
aliquots by dilution with distilled water took only
seconds to carry out.
Dissecting the elements of blocker design
Position eﬀect. Both BLKs in Figure 1 out compete their
respective XPs by binding to the entire target sequence
plus additional bases at the 30-end. But, the data shown
in Figure 2 demonstrate that several BLKs with similar
melting temperatures are equally eﬀective provided that
they overlap with at least one nucleotide on the 30-end
of the XP. In the examples shown here the lengths of
all the BLKs were adjusted to keep the Tm of
each BLK  10 C higher than that of the XP, 57.8 C.
Figure 1. Obtaining both LP strand and XP strand of G269 and HV1
from their LATE-PCR duplex by Dilute-‘N’-Go sequencing. (a) blocker
design of the G269 BLK, G269_BL and HV1 BLK, HV1_BL; (b) the
binding curve of each XP and BLK on its speciﬁc target and (c)
sequencing results from the G269 and HV1 duplex by Dilute-‘N’-Go
sequencing methods.
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is positioned on the target before the XP has a chance to
bind.
Figure 2 shows the G269 XP strand sequence in the
absence or presence of one of several possible HV1
BLKs. When no BLK was added, both the G269 and
HV1 sequences are generated and overlap. When only a
single nucleotide of the HV1 BLK overlaps the 30-end of
XP the base call of the G269 sequence is accurate,
although there is a slight background of the HV1
sequence. Additional experiments, however, demonstrate
that blocking does not occur if the blocker binds to the
target beyond the 30-end of the XP (data not shown).
Blocker Tm eﬀect. In order to examine the relationship
between BLK Tm and XP Tm independently of other
factors, we designed four BLKs of the HV1 XP that
have zero, one, two or three mismatches with the corre-
sponding target, Figure 3. Each of the mismatches causes
the Tm of the BLK to decrease a few degrees. One HV1
BLK, HV1_BL, is perfectly complementary to the target
and has a Tm 14 C higher than that of the HV1 XP. The
target is completely bound by the BLK prior to binding
the XP. The Tm of the BLK with one mismatch,
HV1_BL6, is 66 C. While BLKs with two mismatches,
HV1-BL7, and with three mismatches, HV1_BL8, have
Tms of 60 and 57.2 C respectively, which are just 2 C
higher or even lower than the Tm of HV1 XP.
As shown in Figure 3, a clean G269 sequence was
obtained when the Tm of the BLK was more than 8 C
above the Tm of HV1 XP. But, the G269 sequence was
not free of interfering sequences when the Tm of the BLK
was only 2 C higher than the Tm of the HV1 XP.
Concentration eﬀect. The melting temperature of two
complementary oligonucleotide strands depends in part
on their concentrations (15–17). Tm of an XP is higher
at high concentration than it is at low concentration.
Each XP in the HV1 & G269 duplex reaction is present
at 1000nM and is estimated at  500nM after 20–30 cycles
of linear ampliﬁcation. When the ampliﬁcation products
are then diluted and sequenced using the Dilute-‘N’-Go
protocol the ﬁnal concentration of the XP is  25nM.
Overall this translates into a decrease in the Tm of the
HV1 XP from 64 to 57.8 C.
We designed an HV1 BLK, HV1-EB, which has the
same sequence as the XP but capped at the 30-end
(Figure 4a). The Tm of HV1-EB increases from 53.5 to
65.9 C when its concentration is raised from 2.5nM to
5mM. Figure 4b demonstrates that the G269 sequence
from the G269 XP becomes cleaner as the concentration
of HV1-EB increases. At a concentration of 500nM the
BLK Tm is 4.6 C higher than the XP Tm and the G269
sequence is clean. These results are consistent with those
of Figure 3 and allow us to conclude that a Tm diﬀerence
of  5 C between the BLK and the XP is suﬃcient for full
blocking, except as described below.
Secondary structure eﬀect. In yet another LATE-PCR
assay we used the TSD & Globin amplicons (see
‘Materials and Methods’ section) to test the eﬃcacy of
blockers in a duplex reaction, Figure 5. The Tm of TSD
XPis67 CwhiletheTmofGlobinXPisstill 61 C.BLKs,
TSD-BL and Globin-BL, were designed with Tms about
10 C higher than their corresponding XPs. The sequencing
results for the two XP strands in this duplex are shown in
Figure 5a. As expected both sequences are present in the
absence of any BLK. In contrast, TSD XP generated a
clean sequence in the presence of the Globin-BL. But,
Globin XP did not generate a clean sequence in the
presence of the TSD-BL. Further analysis revealed that
the TSD-BL forms a hairpin at 50 C, Figure 5b, which
renders it ineﬀective as a blocker. We therefore modiﬁed
the blocker sequence by introducing a mismatch which
destabilized the stem. Blocker TSD_BLm, Figure 5c,
does not form a hairpin at 50 C and eﬃciently blocks the
TSD excess primer as shown in Figure 5a.
Figure 3. Eﬃciency of blockers in correlation with the Tm of the
blocker binding on its target. Here the blockers from top to bottom
are HV1_BL, HV1_BL6, HV1_BL7 and HV1_BL8, which have zero,
one, two or three mismatches with the target, respectively.
Figure 2. Eﬃciency of blockers in correlation with the position where
the blocker binds to the target. Here the blockers from top to bottom
are HV1_BL, HV1_BL1, HV1_BL3 and HV1_BL4, which have 19, 18,
3 or 1 nucleotide overlap with the 30-end of HV1 XP, respectively.
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LATE-PCR assay
We are interested in detecting mutations that accumulate
in mitochondrial genomes due to aging, diabetes and envi-
ronmental damage. Because these mutations are rare it is
important to sequence both strands of each amplicon to
verify that changes in one strand are not due to sequencing
errors (14). In order to pursue this inquiry we have built a
triplex LATE-PCR assay for three genes in the human
mitochondrial genome HV1, HV2 and Cyt b (see
‘Materials and methods’ section). The amplicons
generated in this reaction are 425–541 base pairs long
and Figure 6 shows the results of sequencing all six
strands using the Dilute-‘N’-Go protocol with appropriate
BLKs. Three aliquots of the reaction were used to
sequence the LP strands by adding back the correspond-
ing LPs without any BLK. Three additional aliquots were
used to sequence the XP strands by adding two BLKs that
prevented extension of the remaining two XPs in the
reaction. But, sequencing the whole HV2 amplicon failed
because it contains a string of Gs (or Cs) followed by a
string of Ts (or As). Only the sequence before the Gs (or
Cs) were obtained. Extensive trials with Genewiz, Inc
established that this was a sequencing problem indepen-
dent of the Dilute-‘N’-Go protocol. To circumvent this
problem we designed an inner HV2 sequencing primer,
HV2_LPs2, which hybridizes to the HV2 XP strand down-
stream of the string of Cs. It was added to an aliquot of
the reaction instead of the LP used for LATE-PCR ampli-
ﬁcation and it generated the downstream portion of the
relevant sequence. To sequence the second part of HV2
XP strand we blocked all three of the XPs used for ampli-
ﬁcation and added an inner sequencing primer,
HV2_XPs2, which hybridizes downstream of the string
of Ts in its template. The sequence of the whole HV2
amplicon can be obtained by combining the ﬁrst part
driven by HV2 LP (or XP) and the second part driven
by HV2 LPs2 (or XPs2). Clean sequences for all strands
in the triplex LATE-PCR reaction are obtained as shown
in Figure 6.
Figure 4. Eﬃciency of blockers in correlation with the concentration of
the blocker. (a) HV1 blocker, HV1_EB, has the same sequence of XP
with a BHQ-1 at the 30-end and (b) G269 XP strand sequence obtained
from the G269 and HV1 duplex with diﬀerent concentrations of the
HV1 BLK included in the Dilute-‘N’-Go sequencing.
Figure 6. Sequence of all six strands of mitochondrial DNA HV1,
HV2 and Cyt b by Dilute-‘N’-Go sequencing. The blockers used here
were HV1_BL, HV2_BL and Cytb_BL. HV2_LPs2 and HV2_XPs2
were used to get the second part of the HV2 LP or XP strand.
Figure 5. Sequencing from duplex of TSD and Globin. (a) sequencing
from the duplex with Globin or TSD BLK; (b) the secondary structure
of TSD-BL and (c) the secondary structure of TSD-BLm, a modiﬁed
TSD blocker with a nucleotide mismatch to its target.
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This study demonstrates that Dilute-‘N’-Go sequencing
with added blockers or LPs is a convenient and accurate
method for rapidly preparing and sequencing all of the
oligonucleotide strands generated in a LATE-PCR
multiplex reaction. In contrast, all other protocols for
sample preparation prior to dideoxy sequencing are time
consuming and expensive (6).
The concept of preventing primer extension by addition
of a competitive oligonucleotide has been used before. For
instance, Gillespie turned symmetric PCR into asymmetric
by stopping the reaction after 10–50 thermal cycles and
adding a blocker to one of the primers (18). Nordstro ¨ m
et al. (19) carried out pyrosequencing from a double-
stranded DNA template by adding two non-extendable
oligonucleotides to prevent hybridization of both the
forward and backward primers and also added an inner
sequencing primer. In addition, allele speciﬁc PCR assays
have been described in which a primer that is perfectly
matched to the mutant but mismatch to the wild type is
enhanced by addition of a blocker that is perfectly
matched to the wild type strand but mismatched to the
mutant strand, thereby making ampliﬁcation of wild type
less eﬃcient than that of the mutant (20,21).
In contrast to these previous reports the study reported
here investigated the design criteria of blockers needed to
achieve eﬃcient dideoxy sequencing of all strands in a
multiplex LATE-PCR assay. Our results clearly show
that eﬃcient blocking of each XP depends on three inde-
pendent factors. First, the position of the blocker relative
to the primer is important because the 30-end of the XP
must be prevented from hybridization to its target to
prevent elongation by the DNA polymerase. At least a
single nucleotide overlap is required, but may not be suf-
ﬁcient even if the BLK Tm is much higher than the XP Tm.
Because hybridization is dynamic, reliable blocking
requires an overlap of at least three nucleotides. Second,
the Tm diﬀerence between the BLK and the XP is also
critical. Blocking is eﬃcient when the Tm of the BLK is
at least 5 C higher than that of the Tm of the XP. Finally,
a blocker having a secondary structure with a Tm higher
than the annealing temperature, typically 50 C for
dideoxy sequencing, should be avoided.
We are interested in detecting changes in mitochondrial
genomic sequences that result from aging or drugs. But,
detecting such changes is diﬃcult for two reasons. First,
they are rare and second, the large number of mito-
chondrial genomes in a single cell obscures sequence
changes in a fraction of these genomes. The solution is
to amplify and then sequence portions of individual
mitochondrial genomes. But, multiplex single molecule
ampliﬁcation is not all that is required. The sample must
also be handled free of contamination and sequence
changes that are detected in an ampliﬁed strand of DNA
need to be veriﬁed since they could also be the results of
errors during ampliﬁcation or during sequencing. We have
recently reported that LATE-PCR is a reliable method of
ampliﬁcation starting from single molecules and that
Dilute-‘N’-Go of the two complementary strands of
DNA generated in a monoplex reaction can be used to
validate rare sequence changes (14). Diﬀerent
polymerases, Platinum Taq and Tﬁ( ), have been used
for LATE-PCR ampliﬁcation with no diﬀerence in the
sequencing results. The HV1 and HV2 genes of the
human mitochondrial genome are part of the D-loop
and are known to be variable from person to person,
while the Cyt b gene is conserved within a species.
Preliminary data indicate that treatment of human liver
carcinoma cells with AZT results in accumulation of
mutations in HV2 (Osborne and Wangh, unpublished
results). The present report paves the way for extending
that study to the use of multiplexed LATE-PCR assays.
This approach will be far more cost eﬀective than
amplifying one target at a time.
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